Terms ending in 2036
Every in-force patent on Rarecyte, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,395,367 | Method to Identify Antigen-Specific B Cells for Antibody Development In force · High confidence | Rarecyte, Inc. | In force | High confidence | |
| US 9,442,113 | Method to Identify Antigen-Specific Immune Cells for Therapeutic Development In force · Medium confidence | Rarecyte, Inc. | In force | Medium confidence | |
| US 10,222,373 | Method to Identify Antigen-Specific Immune Cells In force · Medium confidence | Rarecyte, Inc. | In force | Medium confidence | |
| US 11,105,803 | Method to Identify Antigen-Specific Immune Cells In force · Medium confidence | Rarecyte, Inc. | In force | Medium confidence | |
| US 10,072,927 | Detecting a Substrate In force · High confidence | Rarecyte, Inc. | In force | High confidence | |
| US 10,962,362 | Detecting a Substrate In force · High confidence | Rarecyte, Inc. | In force | High confidence | |
| US 10,890,748 | Automated Substrate Loading In force · High confidence | Rarecyte, Inc. | In force | High confidence | |
| US 10,101,247 | Solution and Method for Adhering Suspension Components to a Substrate In force · High confidence | Rarecyte, Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.